Study of NTBC for Tyrosinemia I

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 1998

Study Completion Date

September 30, 2006

Conditions

Tyrosinemia I

Interventions

DRUG

NTBC

Trial Locations (3)

University of Washington School of Medicine, Seattle

Oregon Health Sciences University, Portland

Hopital Sainte Justine, Montreal

All Listed Sponsors

lead

University of Washington

OTHER

NCT00004443 - Study of NTBC for Tyrosinemia I | Biotech Hunter | Biotech Hunter